Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

August 31, 2017

Conditions
Bone Marrow TransplantationHematopoietic Stem CellsMultiple MyelomaLymphoma
Interventions
DRUG

Neupogen

Pharmacological agents often used for stem cell mobilization will be utilized in this study.

PROCEDURE

Hyperbaric oxygen therapy

Exposure to oxygen at 2.4 atmospheres absolute for 90 minutes/day for 3 to 5 days

DRUG

Plerixafor

Pharmacological agents often used for stem cell mobilization will be utilized in this study.

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Healogics

UNKNOWN

lead

University of Maryland, Baltimore

OTHER